BR9804921A - Peptìdeo natriurético atrial (anp) como um aditivo para soluções de diálise peritoneal. - Google Patents

Peptìdeo natriurético atrial (anp) como um aditivo para soluções de diálise peritoneal.

Info

Publication number
BR9804921A
BR9804921A BR9804921-6A BR9804921A BR9804921A BR 9804921 A BR9804921 A BR 9804921A BR 9804921 A BR9804921 A BR 9804921A BR 9804921 A BR9804921 A BR 9804921A
Authority
BR
Brazil
Prior art keywords
anp
peritoneal dialysis
natriuretic peptide
atrial natriuretic
additive
Prior art date
Application number
BR9804921-6A
Other languages
English (en)
Inventor
Chi J Chen
Ty R Shockley
Miles G Johnston
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of BR9804921A publication Critical patent/BR9804921A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Patente de Invenção:<B>"PEPTìDEO NATRIURéTICO ATRIAL (ANP) COMO UM ADITIVO PARA SOLUçõES DE DIáLISE PERITONEAL"<D>. A presente invenção provê uma solução de diálise peritoneal que contém peptídeo natriurético atrial (ANP), um derivado de ANP, um análogo de ANP, uma substância que liga-se a ANP para remoção de receptores ou uma substância que promove síntese de ANP, que resulta em uma ultrafiltração líquida aumentada e aumentada remoção de sódio em pacientes de diálise peritoneal.
BR9804921-6A 1997-05-23 1998-05-21 Peptìdeo natriurético atrial (anp) como um aditivo para soluções de diálise peritoneal. BR9804921A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/862,480 US5965533A (en) 1997-05-23 1997-05-23 Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions
PCT/US1998/010511 WO1998052599A1 (en) 1997-05-23 1998-05-21 Atrial natriuretic peptide (anp) as an additive to peritoneal dialysis solutions

Publications (1)

Publication Number Publication Date
BR9804921A true BR9804921A (pt) 1999-09-08

Family

ID=25338600

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9804921-6A BR9804921A (pt) 1997-05-23 1998-05-21 Peptìdeo natriurético atrial (anp) como um aditivo para soluções de diálise peritoneal.

Country Status (12)

Country Link
US (1) US5965533A (pt)
EP (1) EP0914147B1 (pt)
JP (1) JP2000516836A (pt)
KR (1) KR20000029447A (pt)
CN (1) CN1226832A (pt)
AU (1) AU733210B2 (pt)
BR (1) BR9804921A (pt)
CA (1) CA2261681A1 (pt)
DE (1) DE69808717T2 (pt)
ES (1) ES2186166T3 (pt)
ID (1) ID21765A (pt)
WO (1) WO1998052599A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE303812T1 (de) * 1998-07-07 2005-09-15 Terumo Corp Lösung für die peritonealdialyse
JP2002524723A (ja) * 1998-09-04 2002-08-06 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション パラクリンの尿細管レニン−アンジオテンシン系に基づく薬物スクリーニングおよび診断
US8580746B2 (en) * 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
CA2647146A1 (en) * 2006-03-30 2007-10-11 Palatin Technologies, Inc. Linear natriuretic peptide constructs
KR101434612B1 (ko) * 2006-03-30 2014-08-26 팔라틴 테크놀로지스 인코포레이티드 사이클릭 나트륨 이뇨 펩타이드 구조물
JP5207316B2 (ja) * 2007-05-10 2013-06-12 国立大学法人名古屋大学 腹膜線維化抑制用医薬組成物
AU2010274293B9 (en) 2009-07-23 2013-08-29 Igisu Co., Ltd. Skin external-preparation composition
AU2010287421B2 (en) 2009-08-27 2013-06-13 Kyoko Endo Therapeutic agent for rhinitis
ES2647680T3 (es) 2011-01-21 2017-12-26 Igisu Co., Ltd. Fármaco terapéutico para la alopecia
WO2014197806A2 (en) * 2013-06-07 2014-12-11 Allena Pharmaceuticals, Inc. Compositions, methods, and devices for dialysis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258368A (en) * 1984-04-19 1993-11-02 Scios Nova, Inc. Atrial natriuretic/vasodilator peptide compounds
US5212286A (en) 1984-04-19 1993-05-18 Scios Nova Inc. Atrial natriuretic/vasodilator peptide compounds
US4618600A (en) 1984-04-19 1986-10-21 Biotechnology Research Associates, J.V. Novel polypeptide diuretic/vasodilators
WO1987006938A1 (en) 1986-05-09 1987-11-19 Biotechnology Research Associates, J.V. Atrial natriuretic peptide receptor protein and its encoding dna
WO1989000428A1 (en) * 1987-07-17 1989-01-26 Brigham And Women's Hospital Use of atrial peptide antibodies, receptor antagonists, and atrial peptide synthesis inhibitors in controlling renal and systemic vasodilation in diabetes mellitus
US5114923A (en) 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
EP0429537A4 (en) 1988-08-18 1991-08-21 California Biotechnology, Inc. Atrial natriuretic peptide clearance inhibitors
US5106834A (en) 1988-12-27 1992-04-21 G. D. Searle & Co. Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
US5589197A (en) * 1993-10-04 1996-12-31 Baxter International, Inc. Low sodium peritoneal dialysis solution

Also Published As

Publication number Publication date
JP2000516836A (ja) 2000-12-19
EP0914147B1 (en) 2002-10-16
DE69808717D1 (de) 2002-11-21
US5965533A (en) 1999-10-12
ES2186166T3 (es) 2003-05-01
EP0914147A1 (en) 1999-05-12
CN1226832A (zh) 1999-08-25
AU733210B2 (en) 2001-05-10
CA2261681A1 (en) 1998-11-26
WO1998052599A1 (en) 1998-11-26
AU7692698A (en) 1998-12-11
DE69808717T2 (de) 2003-06-12
ID21765A (id) 1999-07-22
KR20000029447A (ko) 2000-05-25

Similar Documents

Publication Publication Date Title
AR047551A1 (es) Compuestos activos antritranspirantes de aluminio/ zirconio / glicina, estabilizados con betaina
BR9811948A (pt) Secretores de hormÈnio do crescimento
BR9714200A (pt) Análogos de hormÈnio paratiróide
BR9906438A (pt) Composição de reforço nutricional apropriada para o tratamento de úlceras de pressão
BR9913745A (pt) Cetonas de piridina úteis como herbicidas
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
DK0489423T3 (da) Galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelsen af disse forbindelser som lægemidler
BR9804921A (pt) Peptìdeo natriurético atrial (anp) como um aditivo para soluções de diálise peritoneal.
BR9609393A (pt) Composição injetável de colágeno; segmentos de fibra de colágeno reconstituìdos.
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
MX9203370A (es) Desulfatohirudina y composiciones farmaceuticas que la contienen.
BRPI0203172B8 (pt) composição farmacêutica para acondroplasia
AR051512A1 (es) Proteina de fusion que comprende un dominio bh3 de una proteina &#34;solo bh3&#34;
BRPI0504445A (pt) composição de trombina e processo para a sua preparação
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
BRPI0612840A8 (pt) Composição de ração para prevenir ou tratar doença renal, métodos para prevenir ou tratar doença renal e para produzir uma composição de ração, kit, e, meio para comunicar informação ou instruções
BR9811094A (pt) Agente terapêutico para tumores linfáticos
BR9816013A (pt) Proteìna de ligação de interleucina-18
BR0010808A (pt) Composições farmacêuticas e usos
ATE316782T1 (de) Neue orale formulierungen für 5-ht4 agonisten oder antagonisten
ES2187125T3 (es) Compuestos biciclicos-aromaticos y su utilizacion en medicina humana o veterinaria asi como en cosmetologia.
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
BR9913190A (pt) Modulação de proteìnas quinase de linhagemmúltipla
PT1067934E (pt) Solucao anti-depressiva liquida oral
BR0009211A (pt) Derivados de resorcinol

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1892 DE 10/04/2007.